|
Category:
|
7TM Receptors GABAB ReceptorsAntagonists
|
|
Cat.No.
|
Product Name
|
|
1088 |
CGP 54626 hydrochloride
|
|
|
|
Price and Availability
Click here for full price details of
CGP 54626 hydrochloride
Other Information:
Sold
with the permission of Novartis Pharma AG
|
|
Chemical Name:
[S-(R*,R*)]-[3-[[1-(3,4-Dichlorophenyl)ethyl]amino]-2-h
ydroxypropyl](cyclohexylmethyl) phosphinic acid |
|
|
Biological Activity:
A potent, selective GABAB receptor antagonist (IC50
= 4 nM).
|
Technical Data:
|
|
|
Resources:
|
|
Certificate of Analysis / MSDS:
|
References:
Brugger et al (1993) The action of new potent GABAB
receptor antagonists in the hemisected spinal cord preparation of the rat.
Eur.J.Pharmacol. 235 153. Froestl et al (1996)
Potent, orally active GABAB receptor antagonists.
Pharmacol.Rev.Comm. 8 127. Kaupmann et al (1998)
GABAB-receptor subtypes assemble into functional heteromeric
complexes. Nature 396 683.
|
|
View related products by Pharmacological Action
or by Research Area
Keywords: CGP 54626 Hydrochloride, GABAB Receptors, Potent, Selective GABAB Antagonist, CGP54626 Hydrochloride, Tocris Bioscience
|
|
Featured New Product
Antagonist of neurosteroid potentiation of GABAA
2681
17-PA
Selective antagonist of neuro-steroid potentiation and direct gating of GABAA receptors. Selectively reduces the effects of 5α-reduced steroids compared to 5β-reduced steroids & displays no effect on potentiation evoked by barbiturates & benzodiazepines. Attenuates 3α,5α-THP-induced loss of righting reflex and total sleep time following i.c.v administration in rats.
View all Featured New Products
|
